Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0209) | |||||
---|---|---|---|---|---|
DME Name | Pyridoxamine-phosphate oxidase (PNPO), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.4.3.5 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Multilayered rosettes embryonal tumour | Significant hypermethylation | |||
Interaction Name | DNMT-PNPO interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 7.95E-13; delta-beta: 4.13E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the PNPO gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Pyridoxamine-phosphate oxidase. As a result, the interaction between DNMT and PNPO can significantly affect the drug-metabolizing process of Pyridoxamine-phosphate oxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.